Definitive Contract 75A50123C00068
Award Date
9/27/23
Potential Completion Date
9/27/33
Potential Value
$114M
Awardee
Indivior Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
North Chesterfield, Richmond, VA 23236, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer of pharmaceuticals and medical devices. The $1,017,630.00 contract is for the delivery of naloxone nasal spray, a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract is a Delivery Order placed against Emergent Devices' Federal Supply Schedule (FSS-61-IB) contract for pharmaceuticals and drugs. No...
The Department of Veterans Affairs Veterans Health Administration awarded a $934,410.48 firm fixed-price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract is under the Pharmaceuticals and Drugs Federal Supply Schedule, which allows Veterans Integrated Service Network 12 to procure pharmaceuticals through a streamlined vehicle. Emergent Devices, a for-profit...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer of pharmaceuticals and medical devices, to provide naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. The $946,261.44 firm-fixed-price delivery order was placed against Emergent Devices' Federal Supply Schedule 65 IB contract, which furnishes drugs and hematology...
This is a federal contract award to Emergent Devices, Inc., a multinational specialty biopharmaceutical company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of naloxone nasal spray, a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract has a potential value of $1,008,582.12 and is a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract does not...
The Department of Veterans Affairs Veterans Health Administration awarded a $904,465.44 firm fixed price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. Emergent Devices, a for-profit manufacturer, holds a Federal Supply Schedule 65 IB contract to provide pharmaceuticals and drugs to VA facilities through 2028. This delivery order was placed against that larger contract...
The Department of Veterans Affairs Veterans Health Administration awarded Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, a firm-fixed-price delivery order contract to provide naloxone nasal spray. The $904,465.44 contract is under the Pharmaceuticals and Drugs Federal Supply Schedule 61-IB, which allows Emergent Devices to furnish drugs and hematology products to VA facilities through 2028. The naloxone nasal spray rapidly reverses opioid overdoses and treats substance...
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order to Emergent Devices, Inc., a for-profit manufacturer, to provide $466,202.88 worth of naloxone nasal spray. This medication is used to rapidly reverse opioid overdoses and treat substance abuse. The contract was issued under Emergent Devices' Federal Supply Schedule 65 IB contract for pharmaceuticals and drugs, which is valid through August 2028. The Department of Veterans Affairs has used...
This is a federal contract award to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray to the Department of Veterans Affairs Veterans Health Administration. The contract is a $934,875.00 delivery order under Emergent Devices' Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs, which runs through August 2028. The naloxone nasal spray is used to rapidly reverse opioid overdoses and treat substance abuse. Emergent Devices has also received other...
This federal contract award to Emergent Devices, Inc. is for the provision of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract was awarded by the U.S. Department of Veterans Affairs, with a ceiling value of $455,898.24. Emergent Devices is a for-profit pharmaceutical manufacturer that specializes in supplying medical countermeasures to the federal government, including various naloxone formulations to address the ongoing opioid crisis. This contract...
This is a federal contract award to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray to the Department of Veterans Affairs Veterans Health Administration. The $946,261.44 delivery order contract is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is for a firm fixed price. The naloxone nasal spray is used to rapidly reverse opioid overdoses and treat substance abuse. Emergent Devices has held other contracts to supply this medication...